|Abbreviated title (ISO 4)||Neuropsychopharmacol|
|Edited by||William A. Carlezon Jr.|
|Publisher||Nature Publishing Group|
|Open access||Delayed, after 12 months|
Neuropsychopharmacology is a peer-reviewed scientific journal published by the Nature Publishing Group. Since 1987, Neuropsychopharmacology has been the official publication of the American College of Neuropsychopharmacology.
The journal covers topics in neuropsychopharmacology, including clinical and basic science research into the brain and behavior, the properties of agents acting within the central nervous system, and drug targeting and development. According to the Journal Citation Reports, it had a 2012 impact factor of 8.678, making it a top 6 journal in the category "Psychiatry," a top 10 journal in "Pharmacology & Pharmacy" and a top 20 journal in "Neuroscience".
In addition to monthly issues, Neuropsychopharmacology also publishes a special 13th issue in January, called Neuropsychopharmacology Reviews. The 2013 review issue focuses on epigenetics, the modification of genetic expression without changing the underlying DNA, or how environment affects genetic potential. Epigenetics is highly involved in learning and memory, as well as maladaptations caused by stress or drug abuse.
Neuropsychopharmacology produces free podcasts to highlight research reports that may be of particular interest to the public; a podcast is also released in January to complement the Reviews issue.
- Official website
- Neuropsychopharmacology Reviews
- American College of Neuropsychopharmacology (ACNP)
- Neuropsychopharmacology podcasts